With Commodity12, the European Union plans to develop a telemedicine programme to ensure better management of diabetes.
Telemedicine and diabetes
Diabetes monitoring devices are currently one of the most widespread uses of telemedicine technology, along with pacemakers used for monitoring sufferers of sleep apnoea.
Web sites such as MyCareTeam in the US and, DiaSend in Sweden, and mobile apps like Diabeo developed by Sanofi and Glooko (pictured opposite,) an American system for digitally monitoring glucose levels that recently received FDA (Food and Drug Administration) approval, increase patient empowerment on the one hand, whilst facilitating monitoring for healthcare professionals. Such initiatives are a milestone in both diabetes management and new healthcare technologies.
Telemedicine: vital for the future of diabetes management
In Europe in 2011 alone, the IDF (International Diabetes Federation) estimated the cost of diabetes treatment at $130 billion and the number of adult deaths from the disease at 600,000. 8.1% of Europe’s adult population suffer from the disease, with the greatest prevalence in the Russian Federation. What’s more, all these figures are set to rise.
In light of these worrying trends, the European Union has granted €3.7 million to a consortium of 9 organisations, including research institutes, university experts and industrial companies, as part of a project called Commodity12
Commodity12: a complete telemedicine system for diabetics
The aim of Commodity12 (COntinuous Multi-parametric and Multi-layered analysis Of DIabetes TYpe 1 & 2) is to monitor diabetes sufferers using cutting-edge technology such as state-of-the-art networks, software interoperation and artificial intelligence techniques.
The project will involve a trial carried out on patients in Poland and Switzerland, with the aim of ultimately gathering indicators in order to draw up profiles, treatments and procedures to enable greater patient autonomy, monitor patients’ conditions more effectively and reduce hospitalisation rates.
This ambitious research programme also plans to use the results to extend a telemedicine programme across Europe and promote technological innovation in eHealth.